BridgeBio Pharma
BBIO
BBIO
75 hedge funds and large institutions have $2.22B invested in BridgeBio Pharma in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
18% less capital invested
Capital invested by funds: $2.7B → $2.22B (-$478M)
Holders
75
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$43.7M | |
| 2 | +$32.3M | |
| 3 | +$30.5M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$8.34M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.55M |
Top Sellers
| 1 | -$8.18M | |
| 2 | -$7.81M | |
| 3 | -$7.35M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$7.05M |
| 5 |
SM
SCGE Management
Menlo Park,
California
|
-$3.7M |